NCT02542787View on ClinicalTrials.gov

Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Spasticity in People With Multiple Sclerosis
Interventions
DRUG

VSN16R

Small molecule

OTHER

Placebo

dummy tablet

Trial Locations (4)

L9 7LJ

The Neuroscience Research Centre, The Walton Centre NHS Foundation Trust, Liverpool

E1 1BB

The Royal London Hospital, London

WC1N 3BG

The National Hospital for Neurology and Neurosurgery, London

S10 2JFS

Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield

Sponsors
All Listed Sponsors
lead

Canbex Therapeutics Ltd

INDUSTRY